A. Dechaphunkul

发表

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine

Charles Swanton, Gerald Goh, Imjai Chitapanarux, 2016, PLoS medicine.

Osimertinib in Untreated EGFR‐Mutated Advanced Non–Small‐Cell Lung Cancer

Ying Cheng, Y. Ohe, B. Chewaskulyong, 2018, The New England journal of medicine.

Antihormonal Therapy in Breast Cancer

P. Sunpaweravong, A. Dechaphunkul, Manunya Chacranon, 2011 .

Angiosarcoma of the pulmonary artery mimicking pulmonary thromboembolism

A. Dechaphunkul, Keerati Hongsakul, S. Nirattisaikul, 2021, SA journal of radiology.

Metastatic Primary Testicular Neuroendocrine Carcinoma Associated with Somatic Malignant Transformation of Teratoma: A Rare Case Report

P. Sunpaweravong, A. Dechaphunkul, C. Sathitruangsak, 2022, Case Reports in Oncology.

Clinicopathologic characteristics and survival outcomes of patients with advanced esophageal, gastroesophageal junction, and gastric adenocarcinoma: a single-institution experience.

A. Dechaphunkul, J. Deschênes, J. Spratlin, 2012, Current oncology.

Genitourinary small-cell carcinoma: a single-institution experience.

Sunita Ghosh, A. Dechaphunkul, N. Pervez, 2013, Current oncology.

Hepatitis B screening rates and reactivation in solid organ malignancy patients undergoing chemotherapy in Southern Thailand

A. Dechaphunkul, T. Piratvisuth, C. Kongkamol, 2019, Clinical and molecular hepatology.

Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand

A. Dechaphunkul, N. Ngamphaiboon, B. Suktitipat, 2020, BMC Cancer.

Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with locally advanced nasopharyngeal carcinoma: a multicenter analysis in Thailand

A. Dechaphunkul, N. Ngamphaiboon, B. Suktitipat, 2020 .

Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer

J. Mackey, Sunita Ghosh, A. Dechaphunkul, 2012, International journal of breast cancer.

Neurological Complications of Chemotherapy and Radiotherapy in Cancer Patients

A. Dechaphunkul, C. Sathitruangsak, 2014 .

Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non–Small Cell Lung Cancer

Y. Ohe, D. Planchard, S. Ramalingam, 2019, Clinical Cancer Research.

Comparison of 3-weekly cisplatin versus 3-weekly carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicentre analysis

A. Dechaphunkul, B. Suktitipat, P. Danchaivijitr, 2019 .

Cancer-associated Thromboembolism

A. Dechaphunkul, C. Sathitruangsak, Nichanan Tanapathomsinchai, 2014 .

Clinical Characteristics and Treatment Outcomes of Patients with Primary Mediastinal Germ Cell Tumors: 10-Years' Experience at a Single Institution with a Bleomycin-Containing Regimen

P. Sunpaweravong, A. Dechaphunkul, C. Sathitruangsak, 2016, Oncology Research and Treatment.

The effectiveness of a pain management programme on pain control and quality of life in patients with metastatic cancer.

A. Dechaphunkul, C. Sathitruangsak, Apinya Prisutkul, 2022, International journal of palliative nursing.

Common presentation in an uncommon disease: case report of a patient with primary diffuse leptomeningeal melanocytosis.

P. Sunpaweravong, A. Dechaphunkul, K. Kayasut, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response to 5-Fluorouracil-Based Chemotherapy in a Patient with Metastatic Colonic-Type Adenocarcinoma Arising in a Primary Mediastinal Teratoma

M. Sawyer, A. Dechaphunkul, G. Bigras, 2012, Case reports in oncological medicine.

Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.

Sung-Bae Kim, A. Dechaphunkul, É. Remenár, 2017, The Lancet. Oncology.

Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI‐906) or Placebo in Chemotherapy‐Naive Patients With Non–Small‐Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations

C. Rudin, M. Ahn, P. Sunpaweravong, 2017, Clinical lung cancer.

Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort.

A. Dechaphunkul, Sarayut Lucien Geater, T. Dechaphunkul, 2022, American journal of otolaryngology.

Benefits of prophylactic percutaneous gastrostomy in patients with nasopharyngeal cancer receiving concurrent chemoradiotherapy: A multicenter analysis.

A. Dechaphunkul, N. Ngamphaiboon, B. Suktitipat, 2021, American journal of otolaryngology.

Epithelial–Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma

A. Dechaphunkul, P. Thongsuksai, C. Wangmo, 2019, Pathology & Oncology Research.

Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.

A. Dechaphunkul, J. Maneechavakajorn, Chia‐Chi Lin, 2020, European journal of cancer.

Real‐world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis

A. Dechaphunkul, N. Ngamphaiboon, B. Suktitipat, 2022, Asia-Pacific journal of clinical oncology.

Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer—Results from Phase Ib Trial IMU.ACS.001

T. Yau, W. Arpornwirat, A. Dechaphunkul, 2021, Clinical Cancer Research.

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

M. Aapro, A. Dechaphunkul, S. Lu, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Osimertinib in Untreated EGFR‐Mutated Advanced Non–Small‐Cell Lung Cancer

Ying Cheng, Y. Ohe, B. Chewaskulyong, 2018, The New England journal of medicine.

Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP

A. Dechaphunkul, T. Hortiwakul, S. Chusri, 2023, Journal of clinical medicine.

Frequency of PIK3CA mutations in different subsites of head and neck squamous cell carcinoma in southern Thailand

A. Dechaphunkul, P. Thongsuksai, Sarayut Lucien Geater, 2022, Journal of pathology and translational medicine.

Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Hung-Ming Wang, V. Lee, P. Lou, 2021, Clinical Cancer Research.

LBA2_PROsimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFRm advanced NSCLC: FLAURA

Y. Ohe, B. Chewaskulyong, E. Cho, 2017 .

Cetuximab plus chemoradiation with cisplatin and 5-fluorouracil (5-FU) in locally advanced unresectable esophageal squamous cell carcinoma.

P. Sunpaweravong, A. Dechaphunkul, W. Mitarnun, 2011, Journal of Clinical Oncology.

Osimertinib versus Standard of Care EGFR TKI as First‐Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset

Ying Cheng, Y. Ohe, E. Cho, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial

M. Ahn, A. Dechaphunkul, Y. Geng, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Curcumin Mouthwash in Coconut Oil Solvent for Preventing Oral Mucositis in Locally Advanced Head and Neck Cancer Patients

P. Sunpaweravong, A. Dechaphunkul, P. Puttarak, 2023 .

Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study

A. Dechaphunkul, Sarayut Lucien Geater, R. Jiratrachu, 2021, Clinical Nutrition.

LBA6_PROsimertinib vs standard of care (SoC) EGFR-TKI as first-line treatment in patients with EGFR-TKI sensitising mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC): FLAURA Asian subset

Ying Cheng, Y. Ohe, B. Chewaskulyong, 2017 .

Frequency of PIK3CA mutations in head and neck squamous cell carcinoma (HNSCC) in southern Thailand.

A. Dechaphunkul, P. Thongsuksai, T. Dechaphunkul, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy of single dose NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of nausea in patients receiving high dose cisplatin.

A. Dechaphunkul, S. Olivari, S. Lu, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

M. Tsuboi, R. Herbst, F. Shepherd, 2023, The New England journal of medicine.

Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes.

D. Planchard, A. Dechaphunkul, M. Boyer, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

128O Osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with untreated EGFRm advanced NSCLC: FLAURA post-progression outcomes

Y. Ohe, D. Planchard, A. Dechaphunkul, 2018 .

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Ying Cheng, Y. Ohe, B. Chewaskulyong, 2018 .

Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand

A. Dechaphunkul, N. Ngamphaiboon, B. Suktitipat, 2020, BMC Cancer.

Overall survival analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated (EGFRm) stage IB–IIIA non-small cell lung cancer (NSCLC).

M. Tsuboi, R. Herbst, F. Shepherd, 2023, Journal of Clinical Oncology.

Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.

Sung-Bae Kim, C. Swanton, S. Johnston, 2016 .

BERIL-1: A phase II, placebo-controlled study of buparlisib (BKM120) plus paclitaxel in patients with platinum-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).

Sung-Bae Kim, A. Dechaphunkul, É. Remenár, 2016 .

Nineteen-year, real-world experience of first-line combination chemotherapy in patients with metastatic colorectal cancer: a propensity score analysis from southern Thailand

P. Sunpaweravong, A. Dechaphunkul, C. Sathitruangsak, 2023, The Journal of international medical research.

Orbital Metastasis as the First Manifestation of Hepatocellular Carcinoma, and Its Effective Treatment with Combined Dual Immunotherapy: A Case Report and Review of the Literature

P. Sunpaweravong, A. Dechaphunkul, C. Sathitruangsak, 2024, The American journal of case reports.

The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis.

P. Sunpaweravong, A. Dechaphunkul, P. Tanutit, 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.